The FINANCIAL — Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of TRPC6, a receptor-operated cation channel. This potent and selective inhibitor of TRPC6 may alleviate the damage to the lung and decrease the
More
The FINANCIAL — As many people in the United States begin to plan for fall and winter holiday celebrations, CDC offers the considerations to help protect individuals, their families, friends, and communities from COVID-19. The considerations are meant to supplement—not replace—any state, local,
More